 | |
| Clinical data | |
|---|---|
| Other names | Anapregnone; 3-Deketo-6α-methyl-17α-hydroxyprogesterone; 6α-Methyl-17α-hydroxypregn-4-en-20-one |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C22H34O2 |
| Molar mass | 330.512 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Anagestone (INNTooltip International Nonproprietary Name), also known as 3-deketo-6α-methyl-17α-hydroxyprogesterone or as 6α-methyl-17α-hydroxypregn-4-en-20-one, is a progestin which was never marketed.[1]
An acylated derivative, anagestone acetate, was formerly used clinically as a pharmaceutical drug.[1]
While anagestone is sometimes used as a synonym for anagestone acetate, it usually refers to anagestone acetate, not anagestone.
References
- ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 85–. ISBN 978-1-4757-2085-3.
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
 | This article about a steroid is a stub. You can help Wikipedia by expanding it. |
This page was last edited on 25 April 2022, at 03:18